Targeting autophagy to overcome drug resistance in cancer therapy

Area of Science:

• Cellular Biology
• Molecular Biology
• Oncology

Background:

• Autophagy is a fundamental catabolic process crucial for maintaining cellular homeostasis under stress and nutrient deprivation.
• Key regulators of autophagy include the PI3K-Akt-mTOR pathway, Beclin1, Bcl-2, Ras, and p53.
• Autophagy exhibits a dual role in cancer, acting as both a tumor suppressor and an oncogene.

Purpose of the Study:

• To explore autophagy as a potential target for novel anticancer drugs.
• To summarize the therapeutic strategy of targeting autophagy to overcome cancer drug resistance.
• To enhance the efficacy of existing anticancer therapies by modulating autophagy.

Main Methods:

• Review of signaling pathways regulating autophagy.
• Analysis of autophagy's role in cancer progression and drug resistance.
• Summary of preclinical and clinical evidence for autophagy inhibition in cancer therapy.

Main Results:

• Autophagy's complex role in cancer necessitates careful consideration for therapeutic targeting.
• Inhibition of autophagy is a viable strategy to overcome resistance to conventional anticancer drugs.
• Targeting autophagy can potentiate the effects of various anticancer treatments.

Conclusions:

• Autophagy modulation represents a promising therapeutic strategy in oncology.
• Targeting autophagy offers a means to circumvent drug resistance in cancer patients.
• Further research into autophagy regulation and targeted inhibition is warranted for improved cancer treatment outcomes.